InvestorsHub Logo
Followers 69
Posts 7612
Boards Moderated 0
Alias Born 01/10/2014

Re: growingpain post# 369300

Saturday, 08/06/2022 10:02:05 AM

Saturday, August 06, 2022 10:02:05 AM

Post# of 462183
Anavex has ran as large of trials as they had funding for. There was no "messing up", and only since the 2021 capital raise has $AVXL had a decent cash balance to run larger trials.

Also, regarding Rett, "I think he finally realised that he needs larger cohorts and this is the true reason behind expanding the Excellence trial." I doubt Dr.M "finally realized" anything...it's the public that are the ones finally understanding what has been done and why.

"The two upcoming readouts will be the endgame for 2-73 IMO." ... yes very much some put up or shut up moments ahead.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News